Correction: Belfeki et al. State of the Art of Cardiac Amyloidosis. Biomedicines 2023, 11, 1045
Nabil Belfeki, Nouha Ghriss, Mehran Monchi, Cyrus Moini
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAmyloidosis: Diagnosis, Treatment, Outcomes · Parathyroid Disorders and Treatments · Sarcoidosis and Beryllium Toxicity Research
Error in Reference Citation
In the original publication [1], reference 49 “Lanini, S.; Garbuglia, A.R.; Lapa, D.; Puro, V.; Navarra, A.; Pergola, C.; Ippolito, G.; Capobianchi, M.R. Epidemiology of HEV in the Mediterranean basin: 10-year prevalence in Italy. BMJ Open 2015, 5, e007110” has been mistakenly cited.
This reference has been deleted and the citation in the text has been replaced with the correct reference 21: “Gościniak, P.; Baron, T.; Milczarek, S.; Kostkiewicz, M.; Machaliński, B. Updates for the diagnosis and management of cardiac amyloidosis. Adv. Clin. Exp. Med. 2022, 31, 175–185”.
All the references from the 49th have been renumbered in the text and in the reference list.
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
The reference list from the paper itself. Each links out to its DOI / PubMed record.